Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
AssigneeHoechst Marion Deutschland GmbH
InventorsHolger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoechst Marion Deutschland GmbH
InventorsHolger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Estimating the term…
The invention relates to a crystal modification of the compound of the formula I 1 and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
A compound comprising a first crystal modification of
A process for the conversion of a second crystal modification to a first crystal modification having the formula I
A process for the conversion of a second crystal modification to a first crystal modification of formula I
A process for the conversion of a first crystal modification to a second crystal modification of a formula I
A process for the conversion of a first crystal modification to a second crystal modification of a formula I
A process for the conversion of a first crystal modification to a second crystal modification of a formula I
Dependencies are inferred from the claim text.